Ascelia Pharma Presents Orviglance Hepatic Impairment Data and Hosts Q&A with Liver Imaging Experts at the 2023 ESGAR Annual Meeting

Ascelia Pharma presented its Hepatic Impairment Study data, which was showcased at the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Annual Meeting in Valencia, Spain, on June 13-16, 2023. The company also held a Q&A session to discuss liver imaging and unmet needs for patients suffering from severe kidney impairment. The Hepatic Impairment Study showed that Ascelia Pharma..